Navidea Biopharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits